Literature DB >> 18159364

The emerging epidemiology of VRE in Canada: results of the CNISP Passive Reporting Network, 1994 to 1998.

J M Conly1, M Ofner-Agostini, S Paton, L Johnston, M Mulvey, A Kureishi, L Nicolle, A Matlow.   

Abstract

OBJECTIVE: To provide a rapid and efficient means of collecting descriptive epidemiological data on occurrences of vancomycin-resistant enterococcus (VRE) in Canada. DESIGN AND METHODS: Passive reporting of data on individual or cluster occurrences of VRE using a one-page surveillance form.
SETTING: The surveillance form was periodically distributed to all Canadian Hospital Epidemiology Committee members, Community and Hospital Infection Control Association members, L'Association des professionnels pour la prevention des infections members and provincial laboratories, representing 650 health care facilities across Canada. PATIENTS: Patients colonized or infected with VRE within Canadian health care facilities.
RESULTS: Until the end of 1998, 263 reports of VRE were received from 113 health care facilities in 10 provinces, comprising a total of 1315 cases of VRE, with 1246 cases colonized (94.7%), 61 infected (4.6%)and eight of unknown status. (0.6%). VRE occurrences were reported in 56% of acute care teaching facilities and 38% of acute care community facilities. All facilities of more than 800 beds reported VRE occurences compared with only 10% of facilities with less than 200 beds (r2=0.86). Medical and surgical wards accounted for 51.4% of the reported VRE occurences. Sixty-five (24.7%) reports indicated an index case was from a foreign country, with 85.2% from the United States and 14.8% from other countries. Some type of screening was conducted in 50% of the sites.
CONCLUSIONS: A VRE passive reporting network provided a rapid and efficient means of providing data on the evolving epidemiology of VRE in Canada.

Entities:  

Keywords:  Epidemiology; Surveillance; Vancomycin-resistant enterococcus

Year:  2001        PMID: 18159364      PMCID: PMC2094843          DOI: 10.1155/2001/424608

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  24 in total

1.  Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany.

Authors:  R R Reinert; G Conrads; J J Schlaeger; G Werner; W Witte; R Lütticken; I Klare
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities.

Authors:  C A Greenaway; M A Miller
Journal:  Infect Control Hosp Epidemiol       Date:  1999-05       Impact factor: 3.254

3.  Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-08-22       Impact factor: 17.586

Review 4.  Spread of vancomycin-resistant enterococci: why did it happen in the United States?

Authors:  W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1998-08       Impact factor: 3.254

5.  Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.

Authors:  L Lior; M Litt; J Hockin; C Kennedy; B A Jolley; M Garcia; G Gillis; A Humar; I Campbell; J Brunton; H Dedier; J Conly
Journal:  Can Commun Dis Rep       Date:  1996-08-01

6.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

7.  Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany.

Authors:  C Wendt; C Krause; L U Xander; D Löffler; H Floss
Journal:  J Hosp Infect       Date:  1999-07       Impact factor: 3.926

8.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

9.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

10.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus.

Authors:  W C Noble; Z Virani; R G Cree
Journal:  FEMS Microbiol Lett       Date:  1992-06-01       Impact factor: 2.742

View more
  4 in total

1.  Antimicrobial resistance - Judicious use is the key.

Authors:  John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

Review 2.  Antimicrobial resistance in Canada.

Authors:  John Conly
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

3.  Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David Boyd; Marianna Ofner-Agostini; Sara Christianson; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

4.  Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.

Authors:  Stephen Mac; Tiffany Fitzpatrick; Jennie Johnstone; Beate Sander
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-29       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.